NIH-funded research R21 grant

Rapid point-of-care test for syphilis and other genital ulcer infections

Official title: Development of a novel syphilis molecular diagnostic assay for a point-of-care multiplexed genital ulcer panel test on giant magnetoresistive biosensors

Funded at Magic Lifescience, INC. · NIH-11174434 · Data updated 2026-11-12

A small, portable molecular test to quickly detect syphilis (and other causes of genital ulcers) for adults in clinic settings.

More Syphilis research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionMagic Lifescience, INC.
NIH-funded
Lab location1 site (Mountain View, United States)
Project startAugust 21, 2024
Project endJuly 31, 2026
Funding year2025
Award (this year)$180,960
NIH project number5R21AI185972-02
Project IDNIH-11174434 on NIH RePORTER

Who could benefit from this research

Could help

Adults (21+) with suspected genital ulcers, signs of syphilis, or who can provide genital or blood samples for test development would be ideal candidates.

Less likely to help

People without genital ulcer symptoms, children under 21, or those in locations without access to the new device may not benefit directly from this work.

What this research studies

You would provide a genital or blood sample and the team is creating a handheld device that uses molecular testing plus magnetic sensors to find syphilis DNA. The work focuses on the best sample type(s) or combinations to catch congenital, secondary, and latent infections. The magnetic sensor approach aims to give clearer signals than light-based methods and to simplify the device so it can be used at the point of care. The goal is fast, accurate results so treatment can start before you leave the clinic.

Why it matters

Potential benefit: If successful, patients could get reliable syphilis results during a single clinic visit and receive timely treatment instead of waiting days for lab results.

How similar studies have gone: Existing rapid syphilis antibody tests and lab PCRs exist but have limitations, and PCR-based point-of-care devices using giant magnetoresistive sensors are a newer, less clinically proven approach.

Where this research is happening

  • Magic Lifescience, INC.
    Mountain View, United States
    Active

Researchers

  • Principal investigator: Ng, Elaine — Magic Lifescience, INC.
  • Study coordinator: Ng, Elaine

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.